As clinical trials grow more complex, functional service provider (FSP) partnerships help organizations scale specialized expertise while maintaining oversight, quality, and operational control. Traditionally, sponsors have relied on either FSP partnerships or full-service outsourcing (FSO) to support clinical development. However, many are now adopting a mixed FSP/FSO model approach that enables greater flexibility, scalability and performance across clinical development.

In this episode of the From Lab to Launch by Qualio podcast, Dr. Les Enterline, Senior VP and Global Head of Functional Service Partnerships at PPD, part of Thermo Fisher Scientific shares his thoughts on:

• How outsourcing partnerships are evolving
• How sponsors are rethinking outsourcing to meet modern challenges
• Where the future of clinical trial delivery is headed

Listen to the podcast episode below.